Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in <i>RET</i> -Altered Solid Tumors: Analysis of the RETgistry Global Consortium
Sarah Waliany(Global Cancer Institute), Jessica J. Lin(Global Cancer Institute), Lova Sun(University of Pennsylvania), Alexander D. Drilon(Memorial Sloan Kettering Cancer Center), Martin Früh(Kantonsspital St. Gallen), Lori J. Wirth(Massachusetts General Hospital), O. Gautschi(University of Bern), Jyoti D. Patel(Memorial Sloan Kettering Cancer Center), Natalie F. Uy(University of Washington), Urs Weber(University of Colorado Cancer Center), Stephen V. Liu(Georgetown University), Alissa J. Cooper(Massachusetts General Hospital), Katherine E. Smith(Mayo Clinic in Arizona), Christina S. Baik(Seattle Cancer Care Alliance), Misako Nagasaka(University of California, Irvine), Andrew Do(Harvard University), Aaron S. Mansfield(Mayo Clinic), H. Loong(Chinese University of Hong Kong), Georg Pall(University Hospital Innsbruck), Shetal Patel(University of North Carolina at Chapel Hill), Jonathan W. Riess(University of California Davis Medical Center), Daniela Weiler(University of Lucerne), G. Lai(National Cancer Centre Singapore), Tae Min Kim(Seoul National University Hospital), Tejas Patil(University of Colorado Cancer Center), Justin F. Gainor(Global Cancer Institute), Natasha B. Leighl(Princess Margaret Cancer Centre), Julia K. Rotow(Dana-Farber Cancer Institute), Shirish Gadgeel(Henry Ford Health System), Benjamin J. Solomon(Peter MacCallum Cancer Centre), Dae Ho Lee(Asan Medical Center), Daniel S. W. Tan(National Cancer Centre Singapore), Jamie Feng(Princess Margaret Cancer Centre), Kingsley S.Y. Cheung(Chinese University of Hong Kong), S. Ignatius Ou(University of California, Irvine), Christina J. Falcon(Memorial Sloan Kettering Cancer Center), Beow Y. Yeap(Global Cancer Institute), Nathan A. Pennell(Cleveland Clinic)
Cited by 4
Related Papers
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.5k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%
|Journal of Clinical Oncology|2021|1.1k